Cynata Therapeutics Ltd
ASX:CYP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
NaturalShrimp Inc
OTC:SHMP
|
US |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
LNA Sante SA
PAR:LNA
|
FR |
|
V
|
Vox Royalty Corp
NASDAQ:VOXR
|
CA |
|
Kurashiru Inc
TSE:299A
|
JP |
|
Honbridge Holdings Ltd
HKEX:8137
|
HK |
|
Biglari Holdings Inc
NYSE:BH.A
|
US |
|
Chegg Inc
NYSE:CHGG
|
US |
|
China Securities Co Ltd
SSE:601066
|
CN |
|
Y
|
Yoshiharu Global Co
NASDAQ:YOSH
|
US |
|
HBT Financial Inc
NASDAQ:HBT
|
US |
|
Hindustan Construction Company Ltd
NSE:HCC
|
IN |
|
Suntec Real Estate Investment Trust
SGX:T82U
|
SG |
Income Statement
Earnings Waterfall
Cynata Therapeutics Ltd
Income Statement
Cynata Therapeutics Ltd
| Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+169%
|
0
N/A
|
0
-9%
|
0
-25%
|
0
-71%
|
0
-71%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+85%
|
0
-32%
|
0
-6%
|
0
+56%
|
0
-3%
|
0
+36%
|
0
0%
|
0
-48%
|
0
-35%
|
0
-5%
|
0
+27%
|
7
+8 702%
|
7
0%
|
0
-97%
|
0
+98%
|
0
+24%
|
0
-4%
|
0
-35%
|
0
-16%
|
0
-11%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
+12%
|
(0)
+87%
|
(0)
-375%
|
(0)
-5%
|
(0)
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(1)
|
(0)
|
(1)
|
(2)
|
0
|
(3)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(6)
|
(9)
|
(8)
|
(4)
|
(6)
|
(8)
|
(11)
|
(13)
|
(10)
|
(15)
|
(14)
|
(10)
|
(9)
|
(10)
|
(9)
|
|
| Selling, General & Administrative |
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
(4)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(2)
|
(4)
|
(4)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(6)
|
(8)
|
(6)
|
(4)
|
(4)
|
(7)
|
(9)
|
(8)
|
(12)
|
(13)
|
(9)
|
(7)
|
(7)
|
(6)
|
|
| Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
(1)
|
0
|
(1)
|
0
|
(2)
|
0
|
(1)
|
0
|
(1)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
(0)
|
1
|
3
|
7
|
3
|
1
|
0
|
1
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Operating Income |
(2)
N/A
|
(2)
-25%
|
(2)
-2%
|
(2)
-4%
|
(3)
-10%
|
(2)
+23%
|
(2)
+20%
|
(0)
+79%
|
(1)
-148%
|
(2)
-179%
|
0
N/A
|
(3)
N/A
|
(4)
-47%
|
(6)
-47%
|
(6)
0%
|
(5)
+10%
|
(6)
-16%
|
(5)
+14%
|
(5)
+14%
|
(6)
-23%
|
(9)
-49%
|
(8)
+7%
|
(3)
+57%
|
(6)
-74%
|
(8)
-27%
|
(4)
+51%
|
(6)
-63%
|
(10)
-67%
|
(15)
-45%
|
(14)
+4%
|
(10)
+29%
|
(9)
+9%
|
(9)
-5%
|
(8)
+11%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-41%
|
(2)
-10%
|
(2)
-4%
|
(3)
-11%
|
(3)
-10%
|
(2)
+44%
|
(0)
+79%
|
(1)
-179%
|
(2)
-147%
|
0
N/A
|
(3)
N/A
|
(4)
-36%
|
(5)
-28%
|
(5)
-4%
|
(3)
+29%
|
(5)
-30%
|
(5)
-17%
|
(5)
+15%
|
(6)
-26%
|
(8)
-48%
|
(8)
+5%
|
(4)
+55%
|
(6)
-63%
|
(8)
-30%
|
(4)
+48%
|
(5)
-37%
|
(9)
-74%
|
(14)
-50%
|
(14)
+4%
|
(10)
+29%
|
(9)
+9%
|
(9)
-6%
|
(8)
+11%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(0)
|
(1)
|
(2)
|
0
|
(3)
|
(4)
|
(5)
|
(5)
|
(3)
|
(5)
|
(5)
|
(5)
|
(6)
|
(8)
|
(8)
|
(4)
|
(6)
|
(8)
|
(4)
|
(5)
|
(9)
|
(14)
|
(14)
|
(10)
|
(9)
|
(9)
|
(8)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-47%
|
(2)
+0%
|
(2)
-4%
|
(3)
-16%
|
(3)
-10%
|
(2)
+45%
|
(0)
+81%
|
(1)
-217%
|
(2)
-147%
|
0
N/A
|
(3)
N/A
|
(4)
-36%
|
(5)
-28%
|
(5)
-4%
|
(3)
+29%
|
(5)
-30%
|
(5)
-17%
|
(5)
+15%
|
(6)
-26%
|
(8)
-48%
|
(8)
+5%
|
(4)
+55%
|
(6)
-63%
|
(8)
-30%
|
(4)
+48%
|
(5)
-37%
|
(9)
-74%
|
(14)
-50%
|
(14)
+4%
|
(10)
+29%
|
(9)
+9%
|
(9)
-6%
|
(8)
+11%
|
|
| EPS (Diluted) |
-0.39
N/A
|
-0.54
-38%
|
-0.5
+7%
|
-0.38
+24%
|
-0.46
-21%
|
-0.38
+17%
|
-0.16
+58%
|
-0.01
+94%
|
-0.04
-300%
|
-0.1
-150%
|
0
N/A
|
-0.05
N/A
|
-0.06
-20%
|
-0.06
N/A
|
-0.07
-17%
|
-0.04
+43%
|
-0.06
-50%
|
-0.06
N/A
|
-0.05
+17%
|
-0.06
-20%
|
-0.08
-33%
|
-0.08
N/A
|
-0.03
+63%
|
-0.05
-67%
|
-0.06
-20%
|
-0.03
+50%
|
-0.04
-33%
|
-0.07
-75%
|
-0.1
-43%
|
-0.09
+10%
|
-0.05
+44%
|
-0.05
N/A
|
-0.05
N/A
|
-0.04
+20%
|
|